| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |